Search results for "Cardiology"

showing 10 items of 6064 documents

Cross-Country Skiing and Running’s Association with Cardiovascular Events and All-Cause Mortality:A Review of the Evidence

2019

A large body of evidence demonstrates positive, graded effects of PA on cardiovascular disease (CVD) morbidity and mortality with increasing intensity compared with lower PA intensity. Running is often designated as a high-intensity PA with substantial evidence supporting its health benefits. Cross-country skiing is among the most demanding aerobic endurance exercises and requires engaging the upper- and lower-body. Cross-country skiing is often regarded as high-intensity PA, which has been associated with significant health benefits. However, a robust body of evidence identifying the dose-response relation between cross-country skiing volume and health outcomes is sparse. Therefore, this r…

medicine.medical_specialtyhigh-intensity physical activityDisease030204 cardiovascular system & hematologyHealth benefitsliikuntaRisk AssessmentRunningjuoksu03 medical and health sciences0302 clinical medicineskiingRisk FactorsSkiingcardiovascular diseasemedicinerunningHumansAerobic exercise030212 general & internal medicineMortalityIntensive care medicineAdverse effectCross countryexercisebusiness.industryPhysical activityCardiorespiratory fitnesshiihtoBlood pressureCardiorespiratory FitnessCardiovascular DiseasesAthletic InjuriesPhysical Endurancesydän- ja verisuonitauditCardiology and Cardiovascular MedicinebusinessAll cause mortalityfyysinen aktiivisuus
researchProduct

Renin-Angiotensin System Blockade and Mortality in Patients With Hypertension and COVID-19 Infection

2020

To determine the effect renin-angiotensin system blockers on the outcome in patients with hypertension and concurrent COVID-19 infection, we searched PubMed, the Cochrane Library, and Google Scholar for relevant articles. Twelve studies with a total of 16,101 patients met the inclusion criteria. The mortality rate among the users of angiotensin converting enzyme inhibitors or angiotensin receptor blockers was 12.15% and in non-users it was 14.56% (risk ratio 0.70, 95% CI [0.53-0.91], P < 0.007). There was no difference in the risk of death between the use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers (risk ratio 1.09, 95% CI [0.90 -1.32]). We conclude tha…

medicine.medical_specialtyhypertensionCoronavirus disease 2019 (COVID-19)PopulationPneumonia ViralAngiotensin-Converting Enzyme Inhibitors030204 cardiovascular system & hematologyCochrane LibraryGastroenterologyArticleRenin-Angiotensin System03 medical and health sciencesAngiotensin Receptor AntagonistsBetacoronavirus0302 clinical medicineInternal medicineRenin–angiotensin systemmedicineHumansPharmacology (medical)In patient030212 general & internal medicineeducationPandemicsPharmacologyeducation.field_of_studybiologybusiness.industrySARS-CoV-2Mortality rateCOVID-19Angiotensin-converting enzymerenin-angiotensin-aldosterone systemRelative riskbiology.proteinCardiology and Cardiovascular MedicinebusinessCoronavirus InfectionsAngiotensin II Type 1 Receptor BlockersJournal of Cardiovascular Pharmacology and Therapeutics
researchProduct

Serum Uric Acid and Kidney Disease Measures Independently Predict Cardiovascular and Total Mortality: The Uric Acid Right for Heart Health (URRAH) Pr…

2021

Background: Serum uric acid predicts the onset and progression of kidney disease, and the occurrence of cardiovascular and all-cause mortality. Nevertheless, it is unclear which is the appropriate definition of hyperuricemia in presence of chronic kidney disease (CKD). Our goal was to study the independent impact of uric acid and CKD on mortality.Methods: We retrospectively investigated 21,963 patients from the URRAH study database. Hyperuricemia was defined on the basis of outcome specific cut-offs separately identified by ROC curves according to eGFR strata. The primary endpoints were cardiovascular and all-cause mortality.Results: After a mean follow-up of 9.8 year, there were 1,582 (7.2…

medicine.medical_specialtyhyperuricemiaCardiovascular Medicineurologic and male genital diseasesGastroenterologyalbuminuriachemistry.chemical_compoundcardiovascular mortalityInternal medicinemedicineeGFRDiseases of the circulatory (Cardiovascular) systemHyperuricemiaRisk factorOriginal Researchbusiness.industryIncidence (epidemiology)Confoundingalbuminuria; all-cause mortality; cardiovascular mortality; eGFR; hyperuricemiahyperuricemia eGFR albuminuria cardiovascular mortality all-cause mortalitymedicine.diseasechemistryQuartileRC666-701AlbuminuriaUric acidall-cause mortalitymedicine.symptomCardiology and Cardiovascular MedicinebusinessKidney disease
researchProduct

Obstructive Sleep Apnea and the Brain

2018

medicine.medical_specialtyinsomniabrainlcsh:Surgerymultiple sclerosis03 medical and health sciences0302 clinical medicineInternal medicineInsomniaMedicineStrokesleep disruptionneurobehaviouralbusiness.industryMultiple sclerosisSleep apnealcsh:RD1-811medicine.diseasesleep apneastrokeObstructive sleep apneaEditorialfemale030228 respiratory systemCardiologySurgerymedicine.symptombusiness030217 neurology & neurosurgeryFrontiers in Surgery
researchProduct

28 Milrinone is Preferred to Levosimendan for Mesenteric Perfusion in Hypoxia-Reoxygenated Newborn Piglets on Dopamine

2010

28 Milrinone is Preferred to Levosimendan for Mesenteric Perfusion in Hypoxia-Reoxygenated Newborn Piglets on Dopamine

medicine.medical_specialtyintegumentary systembusiness.industryanimal diseasesLevosimendanHypoxia (medical)bacterial infections and mycosesfluids and secretionsDopamineInternal medicineAnesthesiaPediatrics Perinatology and Child HealthCardiologyMedicineMilrinonemedicine.symptombusinessPerfusionmedicine.drugPediatric Research
researchProduct

Brain Oedema and Intracranial Pressure in Superior Sagittal Sinus Balloon Occlusion. An Experimental Study in Pigs

1990

About 2/3 of all patients with thrombosis of the superior sagittal sinus (SSS) develop signs of increased ICP and/or brain oedema (BE). The time of onset and the spectrum of symptoms in SSS thrombosis vary extremely. This variability might be caused by differences in pathomechanism like BE and rise of ICP, parameters studied in the present contribution.

medicine.medical_specialtyintegumentary systemmedicine.diagnostic_testBrain edemabusiness.industrymedicine.diseaseThrombosishumanitiesSSS*Balloon occlusionInternal medicineAnesthesiaReference valuesmedicineCardiologybusinessIntracranial pressureCerebral angiographySuperior sagittal sinus
researchProduct

Evidence, Lack of Evidence, Controversy, and Debate in the Provision and Performance of the Surgery of Acute Type A Aortic Dissection

2011

Acute type A aortic dissection is a lethal condition requiring emergency surgery. It has diverse presentations, and the diagnosis can be missed or delayed. Once diagnosed, decisions with regard to initial management, transfer, appropriateness of surgery, timing of operation, and intervention for malperfusion complications are necessary. The goals of surgery are to save life by prevention of pericardial tamponade or intra-pericardial aortic rupture, to resect the primary entry tear, to correct or prevent any malperfusion and aortic valve regurgitation, and if possible to prevent late dissection-related complications in the proximal and downstream aorta. No randomized trials of treatment or t…

medicine.medical_specialtylaw.inventionsurgeryAneurysmRandomized controlled trialRisk Factorslawmedicine.arterymedicineHumansIntraoperative ComplicationsAortic rupturetype A aortic dissectionAortic valve regurgitationAortic dissectionAortatreatmentevidencebusiness.industryCardiovascular Surgical ProceduresIradmedicine.diseaseAortic AneurysmSurgeryAortic DissectionAcute DiseaseTamponadeCardiology and Cardiovascular MedicinebusinessJournal of the American College of Cardiology
researchProduct

Rehospitalization burden and morbidity risk in patients with heart failure with mid-range ejection fraction

2020

Aims Heart failure with mid-range ejection fraction (HFmrEF) has been proposed as a distinct HF phenotype, but whether patients on this category fare worse, similarly, or better than those with HF with reduced EF (HFrEF) or preserved EF (HFpEF) in terms of rehospitalization risks over time remains unclear. Methods and results We prospectively included 2961 consecutive patients admitted for acute HF (AHF) in our institution. Of them, 158 patients died during the index admission, leaving the sample size to be 2803 patients. Patients were categorized according to their EF: HFrEF if EF ≤ 40% (n = 908, 32.4%); HFmrEF if EF = 41–49% (n = 449, 16.0%); and HFpEF if EF ≥ 50% (n = 1446, 51.6%). Covar…

medicine.medical_specialtylcsh:Diseases of the circulatory (Cardiovascular) systemHeart failure030204 cardiovascular system & hematologyRecurrent events03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicineCause of DeathOriginal Research ArticlesmedicineHumansIn patient030212 general & internal medicineRegistriesOriginal Research ArticleHeart FailureEjection fractionbusiness.industryMorbidity riskIncidenceHeart failure with mid-range ejection fractionStroke VolumeHeart failure with mid‐range ejection fractionmedicine.diseasePrognosisConfidence intervalReadmissionslcsh:RC666-701Heart failureCardiologyCardiology and Cardiovascular Medicinebusiness
researchProduct

Transcatheter indirect mitral annuloplasty induces annular and left atrial remodelling in secondary mitral regurgitation

2020

Abstract Aims Mitral annuloplasty using the Carillon Mitral Contour System (CMCS) reduces secondary mitral regurgitation (SMR) and leads to reverse left ventricular remodelling. The aim of this study was to evaluate the effect of the CMCS on the mitral valve annulus (MA) and left atrial volume (LAV). Methods and results We retrospectively evaluated the data of all patients treated with the CMCS at our centre. Using transthoracic echocardiography, MA diameters were assessed by measuring the anterolateral to posteromedial extend (ALPM) and the anterior to posterior (AP) dimensions, respectively. Also, LAV and left ventricular end‐diastolic volume (LVEDV) were assessed. Patients were examined …

medicine.medical_specialtylcsh:Diseases of the circulatory (Cardiovascular) systemMitral Valve AnnuloplastyCarillon030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineLeft atrialOriginal Research ArticlesInternal medicinemedicineHumansMitral Valve AnnulusOriginal Research Article030212 general & internal medicineMitral AnnuloplastyRetrospective StudiesMitral regurgitationbusiness.industryRemodellingMitral Valve InsufficiencyAtrial Remodelingmedicine.diseaseMitral valve annuluslcsh:RC666-701Heart failureTranscatheterPMVRCardiologyMitral ValveCardiology and Cardiovascular MedicinebusinessLAVPaired AnalysisESC Heart Failure
researchProduct

The Female Sex Confers Different Prognosis in Heart Failure: Same Mortality but More Readmissions

2021

Introduction: Heart failure (HF) is a major cause of morbimortality both in men and women. Differences between sex in etiopathogenesis, response to treatment, and quality of care have been found in patients with HF. Females are usually under-represented in clinical trials and there is no solid evidence demonstrating the influence of sex in the prognostic of chronic HF. The primary objective of this study was to analyse the differences in mortality and probability of hospital readmission between males and females with HF. The secondary objective was to compare mortality and probability of hospital readmission by ejection fraction (reduced vs. preserved).Methods: Patients with decompensated H…

medicine.medical_specialtylcsh:Diseases of the circulatory (Cardiovascular) systemMultivariate analysisheart failuremorbidity030204 cardiovascular system & hematologyCardiovascular Medicinereadmissions03 medical and health sciencesBasal (phylogenetics)0302 clinical medicineInternal medicinegenderMedicinesex030212 general & internal medicineOriginal ResearchHospital readmissionEjection fractionbusiness.industryFemale sexleft ventricular ejection fractionmedicine.diseaseResponse to treatmentmortalityClinical triallcsh:RC666-701Heart failureCardiologyCardiology and Cardiovascular MedicinebusinessFrontiers in Cardiovascular Medicine
researchProduct